Latest news
Did Alkermes’ (ALKS) Profit Slide and Cash-Conserving Moves Just Shift Its Investment Narrative? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 09:37:03 GMTTakeda approval ushers in new wave of sleep drugs - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 16:10:45 GMTLet the orexin market begin: Takeda snags FDA approval for narcolepsy type 1 drug - Endpoints NewsEndpoints News · Wed, 05 Aug 2026 21:34:58 GMTHRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up - TradingViewTradingView · Wed, 05 Aug 2026 18:50:00 GMTIs Alkermes (ALKS) Priced For Orexin Success Or Too Rich? - Yahoo FinanceYahoo Finance · Sat, 01 Aug 2026 07:00:00 GMTAlkermes’ Q2 Beat Put Its Orexin Pipeline Back In Focus - FinimizeFinimize · Wed, 29 Jul 2026 20:10:29 GMTAlkermes plc Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTAlkermes set to report earnings amid orexin frenzy and M&A buzz - Investing.com AustraliaInvesting.com Australia · Mon, 27 Jul 2026 13:57:47 GMT